Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C19H17F6N3O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1422127-02-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1422127-02-3 Structure
  • Basic information

    1. Product Name: C19H17F6N3O2S
    2. Synonyms: C19H17F6N3O2S
    3. CAS NO:1422127-02-3
    4. Molecular Formula:
    5. Molecular Weight: 465.419
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1422127-02-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C19H17F6N3O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C19H17F6N3O2S(1422127-02-3)
    11. EPA Substance Registry System: C19H17F6N3O2S(1422127-02-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1422127-02-3(Hazardous Substances Data)

1422127-02-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1422127-02-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,2,1,2 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1422127-02:
(9*1)+(8*4)+(7*2)+(6*2)+(5*1)+(4*2)+(3*7)+(2*0)+(1*2)=103
103 % 10 = 3
So 1422127-02-3 is a valid CAS Registry Number.

1422127-02-3Downstream Products

1422127-02-3Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

-

, (2013/03/26)

The present invention provides a novel compound having a superior activity as an ERR-alpha modulator and useful as an agent for the prophylaxis or treatment of ERR-alpha associated diseases. The present invention relates to a compound represented by the formula (1) wherein each symbol is as defined in the specification, or a salt thereof

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1422127-02-3